These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 22205231)

  • 1. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
    Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
    Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
    Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
    Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
    Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
    Qi S; Wu D
    Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure.
    Villanueva S; Carreño JE; Salazar L; Vergara C; Strodthoff R; Fajre F; Céspedes C; Sáez PJ; Irarrázabal C; Bartolucci J; Figueroa F; Vio CP
    Clin Sci (Lond); 2013 Aug; 125(4):199-210. PubMed ID: 23480877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
    Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
    Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
    Gao J; Liu R; Wu J; Liu Z; Li J; Zhou J; Hao T; Wang Y; Du Z; Duan C; Wang C
    Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
    Jiao X; Cai J; Yu X; Ding X
    Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.
    Park JW; Cho JW; Joo SY; Kim CS; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
    Eur J Pharmacol; 2012 May; 683(1-3):301-9. PubMed ID: 22449373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.
    Zhou Y; Xu H; Xu W; Wang B; Wu H; Tao Y; Zhang B; Wang M; Mao F; Yan Y; Gao S; Gu H; Zhu W; Qian H
    Stem Cell Res Ther; 2013 Apr; 4(2):34. PubMed ID: 23618405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
    Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
    Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
    Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
    Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of mesenchymal stem cells overexpressing GDNF ameliorates renal function in nephrotoxic serum nephritis.
    Huang ZY; Hong LQ; Na N; Luo Y; Miao B; Chen J
    Cell Biochem Funct; 2012 Mar; 30(2):139-44. PubMed ID: 22105543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway.
    Fang Y; Tian X; Bai S; Fan J; Hou W; Tong H; Li D
    Int J Mol Med; 2012 Jul; 30(1):85-92. PubMed ID: 22552764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of naringin and adipose tissue-derived mesenchymal stem cell on cisplatin nephrotoxicity through Sirtuin1/Nrf-2/HO-1 signaling pathway: a promising nephroprotective candidate.
    Amini N; Nejaddehbashi F; Badavi M; Bayati V; Zahra Basir
    Cell Tissue Res; 2024 Sep; 397(3):193-204. PubMed ID: 38953985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells.
    Qian H; Yang H; Xu W; Yan Y; Chen Q; Zhu W; Cao H; Yin Q; Zhou H; Mao F; Chen Y
    Int J Mol Med; 2008 Sep; 22(3):325-32. PubMed ID: 18698491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.